These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6109387)

  • 21. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coronary disease and antihypertensive treatment with beta blockers in older patients].
    Wikstrand J
    Cardiologia; 1984; 29(1-2):129-44. PubMed ID: 6152540
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of medical therapy on long-term survival in ischemic heart disease].
    Caruzzo C; Sechi A; Monti C; Campagna G; Spinnler MT
    Minerva Cardioangiol; 1984 Dec; 32(12):887-93. PubMed ID: 6152332
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 25. [Beta-blockers in coronary disease].
    Carlier J
    Rev Med Liege; 1981 Oct; 36 Suppl 1():17-25. PubMed ID: 6119755
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of beta-adrenergic receptor antagonists in the prevention of sudden cardiac death.
    Gillis AM; Clusin WT
    Compr Ther; 1984 Sep; 10(9):60-7. PubMed ID: 6207977
    [No Abstract]   [Full Text] [Related]  

  • 27. [Secondary prevention of myocardial infarct with beta blockers].
    Vacheron A; Baubion N; Delage F
    J Pharmacol; 1983; 14 Suppl 2():169-75. PubMed ID: 6138466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of sudden death in ischemic heart disease].
    Tsolov Ts
    Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
    [No Abstract]   [Full Text] [Related]  

  • 30. [Secondary prevention after myocardial infarction--beta blockade and acetylsalicylic acid is the basic therapy].
    Bergstrand R; Johansson S; Ulvenstam G; Aberg A; Wilhelmsen L
    Lakartidningen; 1989 Jan; 86(1-2):47-50. PubMed ID: 2562999
    [No Abstract]   [Full Text] [Related]  

  • 31. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
    Bots ML; Grobbee DE
    J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-blocker].
    Anzai T
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():445-9. PubMed ID: 22519031
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prophylactic perioperative beta-blockade reduces cardiac morbidity and mortality following non-cardiac surgery in patients at risk].
    Damen J; Bax JJ; Kolkman E; Poldermans D
    Ned Tijdschr Geneeskd; 2004 Feb; 148(6):268-75. PubMed ID: 15004953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term drug prevention of cardiovascular diseases (methodological aspects)].
    Metelitsa VI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):103-7. PubMed ID: 6139116
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials and ischaemic heart disease: can drugs reduce coronary mortality?
    Silke B; Nelson GI; Taylor SH
    Ir Med J; 1982 Aug; 75(8):297-303. PubMed ID: 6127330
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta blockade.
    Shah S
    Indian Heart J; 1972 Jun; 24():Suppl 1:143-5. PubMed ID: 4147271
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coronary surgery--treatment, choice of surgical technic and results].
    Meisner H; Mayr N; Schmidt-Habelmann P; Struck E; Sebening F
    Chirurg; 1983 Nov; 54(11):715-21. PubMed ID: 6140132
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of beta-blockers in the long-term prevention of morbidity and mortality after myocardial infarction].
    Haïat R; Desoutter P
    Coeur Med Interne; 1980; 19(1):61-5. PubMed ID: 6103776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.